Filing search / Centessa Pharmaceuticals plc / "Incentivize"

DEFA14A

CNTA Centessa Pharmaceuticals plc

20 May 24

Additional proxy soliciting materials

8:48pm

attracting key talent, it was critical for the Company to be able to retain, appropriately incentivize and develop high caliber talent. In order to enable … , incentivize and retain a high calibre team to enable the Company to deliver on the Company’s core objectives and deliver value to shareholders. As we move

PRE 14A

CNTA Centessa Pharmaceuticals plc

26 Apr 24

Preliminary proxy

4:36pm

executive officers. In addition, we believe that equity grants promote retention because they incentivize our executive officers, including our named … key talent, it was critical for the Company to be able to retain, appropriately incentivize and develop high caliber talent. In order to enable

DEFA14A

9ea6pd5 ag

23 May 23

Additional proxy soliciting materials

4:08pm

8-K

db59sdcd2cby50z9ajw

8 Jul 22

Departure of Directors or Certain Officers

4:32pm

DEFA14A

m4djqlw2r9w8h

9 Jun 22

Additional proxy soliciting materials

9:06am

DEF 14A

0ic2s ub0ypkobh7lwk

23 May 22

Definitive proxy

8:00am

424B4

xznwu kbfs2mrjo54v

1 Jun 21

Prospectus supplement with pricing info

4:07pm

S-1/A

6zdl7f9c5r2txpb1crt

12 May 21

IPO registration (amended)

5:19pm

S-1

oa5zt8svnznr9hrp

21 Apr 21

IPO registration

10:14am

CORRESP

z2f5 s6d3re

21 Apr 21

Correspondence with SEC

12:00am

UPLOAD

to9jhwcdjryg3ou

14 Apr 21

Letter from SEC

12:00am